The findings of this study suggest that patients with DM with a previous history of hypoglycaemic events, and who are using intensive antidiabetic therapy with a high risk of developing hypoglycaemia (such as insulin and insulin secretagogues), should receive educational programmes that focus on developing their ability to recognise, analyse and solve their health problems [38–40]. The gene discussed is INS; the disease is diabetes mellitus.